1. Metastatic role of mammalian target of rapamycin signaling activation by chemoradiotherapy in advanced rectal cancer
- Author
-
Manabu Kaneko, Kazushige Kawai, Masamichi Okada, Yasutaka Shuno, Hirofumi Sonoda, Soichiro Ishihara, Koji Murono, Takeshi Nishikawa, Hiroshi Shiratori, Toshiaki Tanaka, Hiroaki Ishii, Keisuke Hata, Kazuhito Sasaki, Hiroaki Nozawa, Tetsuo Ushiku, and Shigenobu Emoto
- Subjects
Male ,0301 basic medicine ,Cancer Research ,Colorectal cancer ,Cell ,epithelial–mesenchymal transition ,Disease-Free Survival ,chemoradiotherapy ,Metastasis ,03 medical and health sciences ,0302 clinical medicine ,distant metastasis ,Cell Movement ,Clinical Research ,Cell Line, Tumor ,medicine ,Humans ,Epithelial–mesenchymal transition ,Neoplasm Metastasis ,rectal cancer ,PI3K/AKT/mTOR pathway ,Aged ,Cell Proliferation ,Ribosomal Protein S6 ,Rectal Neoplasms ,business.industry ,TOR Serine-Threonine Kinases ,Chemoradiotherapy, Adjuvant ,Original Articles ,General Medicine ,Middle Aged ,medicine.disease ,Gene Expression Regulation, Neoplastic ,030104 developmental biology ,medicine.anatomical_structure ,Oncology ,030220 oncology & carcinogenesis ,Cohort ,mTOR ,Cancer research ,Immunohistochemistry ,Female ,Original Article ,Tumor Suppressor Protein p53 ,business ,Chemoradiotherapy ,Signal Transduction - Abstract
Postoperative distant metastasis dramatically affects rectal cancer patients who have undergone neoadjuvant chemoradiotherapy (NACRT). Here, we clarified the association between NACRT‐mediated mammalian target of rapamycin (mTOR) signaling pathway activation and rectal cancer metastatic potential. We performed immunohistochemistry for phosphorylated mTOR (p‐mTOR) and phosphorylated S6 (p‐S6) on surgical specimen blocks from 98 rectal cancer patients after NACRT (cohort 1) and 80 colorectal cancer patients without NACRT (cohort 2). In addition, we investigated the association between mTOR pathway activity, affected by irradiation, and the migration ability of colorectal cancer cells in vitro. Based on the results of the clinical study, p‐mTOR was significantly overexpressed in cohort 1 (with NACRT) as compared to levels in cohort 2 (without NACRT) (P, The postoperative distant recurrence is critical in rectal cancer patients who have received neoadjuvant chemoradiotherapy (NACRT). We investigated NACRT‐mediated mTOR activation and metastatic potential of rectal cancer, identifying p‐S6 expression as a NACRT predictor of postoperative distant metastasis in rectal cancer patients, suggesting that chemoradiotherapy may modulate the mTOR signaling pathway to promote metastasis.
- Published
- 2020
- Full Text
- View/download PDF